Mr. Speaker, as we know now, Health Canada is expediting our authorization processes during the ongoing Sandoz shortage to help hospitals and doctors assess alternative sources of supply in all areas. It is never at the expense of safety, however. Never. The last thing anyone wants to happen is for a patient to be harmed by unsafe drugs authorized in a rush to fill supply gaps. As we know, those supply manufacturers are selected at the provincial level by provincial governments.
Health Canada's rules and regulations for authorizing drugs and the plants they are manufactured in are designed to ensure that drugs sold in Canada are safe, effective and of high quality.